Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Session Item

Mixed sites/palliation
Poster (digital)
Clinical
Radiotherapy - a safe and successful treatment for plantar fasciitis.
Tomasz Latusek, Poland
PO-1445

Abstract

Radiotherapy - a safe and successful treatment for plantar fasciitis.
Authors:

Tomasz Latusek1, Dorota Gabrys1, Grzegorz Wozniak1, Donata Graupner2, Aleksandra Krzywon3, Alexander Jorge Cortez3

1Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Radiotherapy Department, Gliwice, Poland; 2Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, III Department of Radiotherapy and Chemotherapy, Gliwice, Poland; 3Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Biostatistics and Bioinformatics, Gliwice, Poland

Show Affiliations
Purpose or Objective

Plantar fasciitis (PF) is a skeletal disorder of the plantar fascia which affects patients quality of life due to the pain and mobility problems. Because it is one of the most common foot complaint it is a significant social problem. Radiotherapy (RT) represents a relevant method. The aim of the study was to evaluate efficacy and safety of RT in the treatment of PF.

Material and Methods

From the patients treated at the single-institution we retrospectively included 41 patients (54 cases) who were irradiated to a total dose of 6Gy given in 6 fractions five times weekly. Several aspects concerning: symptoms duration before RT, pain localization (the extent) and adverse effects of RT were assessed. The effectiveness of radiotherapy was assessed using the numerical pain rating scale NRS (NRS- numerical rating scale) and German Cooperative Group on Radiotherapy for Non-malignant Diseases (GCG-BD).

Results

The follow-up was 2 years. Taking into account the NRS scale, the mean value of pain after RT decreased in relation to the baseline value during the follow-up period. Before RT, the mean NRS score was 8.5 (range 3-10). Immediately after RT and 3 months after RT, mean scores of 4.8 (range 0-10) and 1.1 were recorded, respectively. During the control period 6-24 months, the mean value of pain according to NRS was 1.1 and subsequently 1.5. Before starting the therapy, the average value according to GCG-BD was 35,2 (range 5-59) what was related to severe pain and significant quality of life deterioration. Immediately after RT and 3, 6, 12 and 24 months after RT the mean value according to GCG-BD was higher (symptoms deterioration and improvement of function) at 59.4 (range 5-100), 88.5 (range 17-100), 88.6 (range 17-100), 92.4 (range 25-100) and 89.5 (range 24-100), respectively. After 24 months pain relief was observed in 89% of patients, including 75.5% with complete pain relief and quality of life improvement even higher than that achieved shortly after RT. This confirms the need for longer time follow up and evaluation of the response to treatment without additional unnecessary therapy since long lasting effects can be found. Analysis of the prognostic factors has shown that only localized pain significantly predicts greater pain relief effect of RT (p<0.05). Other analysed factors for example: duration of symptoms, previous non-RT treatment, type of professional activities were not significant. Mild skin dryness was the only early side effect, observed only in 4% of cases. No late toxicity and secondary malignances were observed.

Conclusion

Radiotherapy for Plantar Fascitis is an effective treatment providing long lasting pain relief and functional improvement without significant toxicity and secondary malignances. Localized pain seems to be positive predictive factor for the effect of therapy.